Potential molecular targets for narrow-spectrum agents to combat Mycoplasma pneumoniae infection and disease

As Mycoplasma pneumoniae macrolide resistance grows and spreads worldwide, it is becoming more important to develop new drugs to prevent infection or limit disease. Because other mycoplasma species have acquired resistance to other classes of antibiotics, it is reasonable to presume that M. pneumoni...

Full description

Bibliographic Details
Main Authors: Mitchell F. Balish, Steven L. Distelhorst
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-02-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.00205/full